EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions

Yong Qiu, Chunheng Mo iD, Lu Chen, Wanlin Ye, Guo Chen, Tao Zhu

MedComm · 2024-04 · 5 (4)

DOI: 10.1002/mco2.513 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 15.03.2024. Verfasst von Yong Qiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology National Clinical Research Center for Geriatrics and The Research Units of West China (2018RU012) West China Hospital Si…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) recently caused a global pandemic, resulting in more than 702 million people being infected and over 6.9 million deaths. Patients with coronavirus disease (COVID‐19) may suffer from diarrhea, sleep disorders, depression, and even cognitive impairment, which is associated with long COVID during recovery. However, there remains no consensus on effective treatment methods. Studies have found that patients with COVID‐19 have alterations in microbiota and their metabolites, particularly in the gut, which may be involved in the regulation of immune responses. Consumption of probiotics may alleviate the discomfort caused by inflammation and oxidative stress. However, the pathophysiological process underlying the alleviation of COVID‐19‐related symptoms and complications by targeting the microbiota remains unclear. In the current study, we summarize the latest research and evidence on the COVID‐19 pandemic, together with symptoms of SARS‐CoV‐2 and vaccine use, with a focus on the relationship between microbiota alterations and COVID‐19‐related symptoms and vaccine use. This work provides evidence that probiotic‐based interventions may improve COVID‐19 symptoms by regulating gut microbiota and systemic immunity. Probiotics may also be used as adjuvants to improve vaccine efficacy.

Schlagwörter

Stichwörter der Autor:innen

COVID‐19gut microbiotaimmunityprobioticsvaccine

Autor:innen und Institutionen

  • Department of Anesthesiology National Clinical Research Center for Geriatrics and The Research Units of West China (2018RU012) West China Hospital Sichuan University Chengdu China.
  • Laboratory of Anesthesia and Critical Care Medicine National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology West China Hospital Sichuan University Chengdu China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE State Key Laboratory of Biotherapy West China Second University Hospital Sichuan University Chengdu China.

ORCID-Profile: Chunheng Mo

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Qiu, Y., Mo, C., Chen, L., Ye, W., Chen, G., & Zhu, T. (2024). Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions. MedComm, 5(4). https://doi.org/10.1002/mco2.513

Vancouver

Qiu Y, Mo C, Chen L, Ye W, Chen G, Zhu T. Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions. MedComm. 2024;5(4). doi:10.1002/mco2.513

BibTeX
@article{Qiu2024,
  author = {Qiu, Yong and Mo, Chunheng and Chen, Lu and Ye, Wanlin and Chen, Guo and Zhu, Tao},
  title = {Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {4},
  doi = {10.1002/mco2.513}
}
Kostenlos starten →